Syros Pharmaceuticals to Present Initial Data from SELECT-AML-1 Phase 2 Trial at 64th ASH Annual Meeting

Stock Information for Syros Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.